CYCL (Cycclone) Stock Based Compensation: $0.00 Mil (TTM As of Jun. 2023)


What is Cycclone Stock Based Compensation?

Cycclone CYCL +19.51% Stock Based Compensation is $0.00 Mil as of Jun. 2023.

Cycclone's Stock Based Compensation for the six months ended in Jun. 2023 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Cycclone Stock Based Compensation Related Terms

Cycclone Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Cycclone's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cycclone Stock Based Compensation Chart

Cycclone Annual Data
Trend Oct06 Oct07 Jun08 Jun22 Jun23
Stock Based Compensation
0.00 0.00 0.00 0.00 0.00

Cycclone Semi-Annual Data
Oct06 Oct07 Jun22 Jun23
Stock Based Compensation 0.00 0.00 0.00 0.00

Cycclone Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Cycclone (CYCL) has a Stock Based Compensation of $0.00 Mil as of Jun. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cycclone and its competitors.
Is Cycclone's Stock Based Compensation too high?
Cycclone's current Stock Based Compensation is $0.00 Mil.
How does Cycclone's Stock Based Compensation compare to EEGI and ATYG?
Cycclone's Stock Based Compensation of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Diversified Financial Services company?
A good Stock Based Compensation depends on the Diversified Financial Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cycclone and its competitors. Cycclone's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cycclone stock overvalued right now?
Cycclone (CYCL) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Cycclone (CYCL), the current Stock Based Compensation is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cycclone Business Description

Address 10/8 Inventory Court, Suite 200-A, Arundel, QLD, AUS, 4214
Cycclone Inc Formerly China Dasheng Biotechnology Co is a design and development company that focuses on permanent magnets as the driving force, rather than a motor. The Company's focus and objective, which is unproven technology, is to invent, design, and develop engines that can supply power on demand utilizing permanent magnets as a driving force.